Multiple primary malignancies in patients with head and neck cancer

Area of Science:

• Oncology
• Radiation Oncology
• Cancer Epidemiology

Background:

• Head and neck cancers are frequently treated with radiation therapy.
• Understanding the long-term risks of secondary malignancies is crucial for patient management.
• Previous studies have indicated a potential link between radiation exposure and subsequent cancers.

Purpose of the Study:

• To determine the incidence and patterns of second independent malignancies in patients treated with radiation for head and neck carcinoma.
• To analyze the risk of secondary cancers based on the primary cancer site and patient survival.
• To investigate the occurrence of second malignancies within the radiation field.

Main Methods:

• Retrospective analysis of 3,162 patients with head and neck carcinoma treated with radiation therapy between 1967 and 1981.
• Calculation of overall and site-specific incidence rates for second malignancies.
• Categorization of second primary sites and analysis of occurrence within the radiation field for long-term survivors.

Main Results:

• The overall incidence of second malignancies was 5.8%, with 8.3% of patients developing two or more independent malignancies.
• Incidences varied by primary cancer site: larynx (8.9%), pharynx (7.7%), oral cavity (5.2%), and paranasal sinus (1.7%).
• Most second primaries were found in the head and neck (36%), digestive tract (35%), and lung (19%). Only 0.7% of five-year survivors developed secondary malignancies within the radiation field.

Conclusions:

• Radiation therapy for head and neck cancer is associated with a significant risk of developing second independent malignancies.
• The majority of second cancers arise in sites distant from the initial radiation field.
• Long-term surveillance is essential for patients treated for head and neck cancers to detect secondary malignancies early.